Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR
Jun Yan, Yuzhu Xu, Xing Jin, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113897-113897
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Selenium as an emerging versatile player in heterocycles and natural products modification
Wei Hou, Hewei Dong, Xiang Zhang, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2268-2277
Closed Access | Times Cited: 61
Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer
Amr Ahmed WalyEldeen, Salwa Sabet, Haidan M. El-Shorbagy, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110297-110297
Closed Access | Times Cited: 58
Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones
Teodora Constantinescu, Alin Grig Mihis
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11595-11595
Open Access | Times Cited: 29
Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers
Xin-Ying Yuan, Chun-Hong Song, Xiujuan Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115281-115281
Closed Access | Times Cited: 17
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 6
Unlocking therapeutic potential: exploring indole scaffolds and their structural insights as pharmacophores in designing anti-breast cancer agents
Adithya Vinod, H. M. Chandra Mouli, Anupam Jana, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 7, pp. 1100-1132
Closed Access | Times Cited: 5
Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities
Hamada Hashem, Abdelfattah Hassan, Walid M. Abdelmagid, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1154-1154
Open Access | Times Cited: 5
Design of ROS-Triggered Sesquiterpene Lactone SC Prodrugs as TrxR1 Covalent Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Hui Ren, Yujue Wang, Xinye Wang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization
Hend A. A. Ezelarab, Taha F. S. Ali, Samar H. Abbas, et al.
Molecular Diversity (2023) Vol. 28, Iss. 2, pp. 563-580
Open Access | Times Cited: 10
Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents
Jiahui Yang, Jianmei Lv, Shuxian Cheng, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1265-1283
Closed Access | Times Cited: 10
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Synthesis and Biological Studies of Acetophenone-Based Novel Chalcone, Semicarbazone, Thiosemicarbazone and Indolone Derivatives: Structure-Activity Relationship, Molecular Docking, Molecular Dynamics, and Kinetic Studies
Aynur Farzaliyeva, Halil Şenol, Parham Taslimi, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 140197-140197
Closed Access | Times Cited: 3
Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline
James Melrose, Margaret M. Smith
Frontiers in Bioscience-Elite (2022) Vol. 14, Iss. 4, pp. 27-27
Open Access | Times Cited: 16
Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay
Lexian Chen, Qianqian Lv, Jianghong Cai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Fluoroindole chalcone analogues targeting the colchicine binding site of tubulin for colorectal oncotherapy
Xiaoxia Liu, Jinmei Jin, Ye Wu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115540-115540
Closed Access | Times Cited: 8
Pristimerin inhibits thioredoxin reductase in the treatment of non-small cell lung cancer
Yajun Chu, Qianhe Xu, Xiedong Zhou, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 2
Indole derivatives targeting colchicine binding site as potential anticancer agents
Bharat Goel, Shivani Jaiswal, Shreyans K. Jain
Archiv der Pharmazie (2023) Vol. 356, Iss. 10
Closed Access | Times Cited: 5
Recent advances in the green synthesis of indole and its derivatives using microwave irradiation and the role of indole moiety in cancer
Faisal A. Almalki, Alaa O. Baryyan
Green Chemistry Letters and Reviews (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Synthesis, biological evaluation and mechanism study of a novel indole-pyridine chalcone derivative as antiproliferative agent against tumor cells through dual targeting tubulin and HK2
Mengzhu Zheng, Guangyuan Liu, Yawei Han, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117058-117058
Closed Access | Times Cited: 1
Combating tumor PARP inhibitor resistance: Combination treatments, nanotechnology, and other potential strategies
Rong Wang, Yunxi Liu, Mingqi Liu, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125028-125028
Closed Access | Times Cited: 1
The main biotargets of indole or 2-oxoindole-based hybrids acting as promising antiproliferative agents
Heba A. Hassan, Samar H. Abbas, Eman A. M. Beshr, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2023) Vol. 6, Iss. 4, pp. 174-183
Open Access | Times Cited: 4
Exploring the Therapeutic Potential of Chalcones in Oncology: A Comprehensive Review
Chandra Shekhar Yadav, Iqbal Azad, Abdul Rahman Khan, et al.
Current Bioactive Compounds (2023) Vol. 20, Iss. 6
Closed Access | Times Cited: 4
Design, Synthesis and Cytotoxic Activity Evaluation of Newly Synthesized Amides-Based TMP Moiety as Potential Anticancer Agents over HepG2 Cells
Tarfah Al‐Warhi, Adil Aldhahrani, Fayez Althobaiti, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3960-3960
Open Access | Times Cited: 5
Novel 3-Methyleneisoindolinones Diversified via Intramolecular Heck Cyclization Induce Oxidative Stress, Decrease Mitochondrial Membrane Potential, Disrupt Cell Cycle, and Induce Apoptosis in Head and Neck Squamous Cell Carcinoma Cells
Arti Sharma, Prince Anand, Yogendra Padwad, et al.
ACS Omega (2022) Vol. 7, Iss. 49, pp. 45036-45044
Open Access | Times Cited: 5
Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells
Zheng Yang, Zhengye Liu, Mourboul Ablise, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7697-7697
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top